0001237899-12-000103.txt : 20121218
0001237899-12-000103.hdr.sgml : 20121218
20121218113149
ACCESSION NUMBER: 0001237899-12-000103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121214
FILED AS OF DATE: 20121218
DATE AS OF CHANGE: 20121218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAHL NEIL
CENTRAL INDEX KEY: 0001226689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 121270453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2012-12-14
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001226689
STAHL NEIL
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Res and Devel Sciences
Common Stock
2012-12-14
4
F
0
8386.0
179.13
D
43036.0
D
Common Stock
2012-12-17
4
M
0
5952.0
16.8
A
48988.0
D
Common Stock
5479.0
I
By 401(k) Plan
Incentive Stock Option (right to buy)
16.8
2012-12-17
4
M
0
5952.0
D
2018-12-17
Common Stock
5952.0
0.0
D
Non-Qualified Stock Option (right to buy)
21.25
2012-12-14
4
A
0
75000.0
A
2019-12-18
Common Stock
75000.0
120295.0
D
Non-Qualified Stock Option (right to buy)
179.13
2012-12-14
4
A
0
112500.0
A
2022-12-14
Common Stock
112500.0
112500.0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
On December 18, 2009, the reporting person was granted an option to purchase 75,000 shares of Common Stock. The option vests, partially or in full, on December 31, 2012, based on the extent to which the company satisfies certain performance criteria during the period ending December 31, 2012. The performance criteria have been met and the option will vest as to all 75,000 shares on December 31, 2012.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Neil Stahl
2012-12-18